ABEO: BLA Resubmission in 2H24
On May 15, 2024, Abeona Therapeutics, Inc. (ABEO) announced financial results for the first quarter of 2024 and provided a business update. The...
Abeona Therapeutics Inc (ABEO) - Thursday, Feb 15, 2024
Abeona is developing a cell therapy for the rare disease RDEB, with FDA review ongoing and a target action date of May 25th
No more insights